| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 23.796 | 172.063 | 402.621 | 571.244 |
| Total Income - EUR | - | - | - | - | - | - | 23.796 | 172.861 | 402.622 | 571.357 |
| Total Expenses - EUR | - | - | - | - | - | - | 11.926 | 146.664 | 332.095 | 502.452 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 11.869 | 26.196 | 70.527 | 68.905 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 11.820 | 24.502 | 67.105 | 50.419 |
| Employees | - | - | - | - | - | - | 0 | 0 | 7 | 9 |
Check the financial reports for the company - Oftanox S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 11.566 | 102.496 | 89.417 | 94.474 |
| Current Assets | - | - | - | - | - | - | 9.078 | 24.993 | 128.935 | 68.985 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 5.953 |
| Receivables | - | - | - | - | - | - | 4.022 | 24.421 | 108.289 | 61.721 |
| Cash | - | - | - | - | - | - | 5.057 | 572 | 20.646 | 1.110 |
| Shareholders Funds | - | - | - | - | - | - | 11.860 | 24.551 | 81.358 | 50.468 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 8.838 | 102.938 | 137.476 | 113.234 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftanox S.r.l.